18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma
Academic Radiology · 2026-01 · 33 (1) · 201-213
DOI: 10.1016/j.acra.2025.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-01. Verfasst von Jingtao Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal & Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, China (J.C., Z.Z., Z.J., P.M., Z.J., C.L…. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Liver Neoplasms. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Health Commission of the People's Republic of China, Zhejiang Province Science and Technology Department, Science and Technology Program of Zhejiang Province.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: To develop and validate a preoperative predictive model for occult liver metastases (OLM) in pancreatic ductal adenocarcinoma (PDAC) using fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET) radiomics. MATERIAL AND METHODS: This retrospective study included 117 patients with PDAC who underwent preoperative 18F-FDG PET/CT and surgical resection. OLM was defined as liver metastases detected during surgery or within 6 months postoperatively. A fully automated pancreas segmentation strategy was employed, and radiomic features were extracted from PET images. Three machine learning models (logistic regression, multilayer perceptron, and adaptive boosting) were developed and compared to a clinical model incorporating jaundice, metabolic tumor diameter, and maximum standardized uptake value. A fusion model integrating PET radiomic features with clinical variables was subsequently constructed. Model performance was evaluated using receiver operating characteristic curves and decision curve analysis. RESULTS: Among the 117 patients, 15.4% (n=18) had OLM. The logistic regression radiomics model demonstrated favorable predictive performance (area under the curve [AUC]: 0.936 in the testing cohort) compared to a clinical model based on conventional parameters (AUC: 0.755, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal & Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, China (J.C., Z.Z., Z.J., P.M., Z.J., C.L., Q.Z., Y.M., W.J.); Postgraduate Training Base Alliance of Wenzhou M…
- Department of Gastrointestinal & Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, China (J.C., Z.Z., Z.J., P.M., Z.J., C.L., Q.Z., Y.M., W.J.).
- Department of Gastrointestinal & Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, China (J.C., Z.Z., Z.J., P.M., Z.J., C.L., Q.Z., Y.M., W.J.). Electronic address: jinww@zju.edu.cn.
Förderung
- National Health Commission of the People's Republic of China
- Zhejiang Province Science and Technology Department
- Science and Technology Program of Zhejiang Province
Zitieren
APA
Chen, J., Zhang, Z., Jin, Z., Ma, P., Jiang, Z., Lu, C., Zhu, Q., Mou, Y., & Jin, W. (2026). 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. Academic Radiology, 33(1), 201-213. https://doi.org/10.1016/j.acra.2025.10.024
Vancouver
Chen J, Zhang Z, Jin Z, Ma P, Jiang Z, Lu C, et al. 18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma. Academic Radiology. 2026;33(1):201-213. doi:10.1016/j.acra.2025.10.024
BibTeX
@article{Chen2026,
author = {Chen, Jingtao and Zhang, Zhiang and Jin, Ze and Ma, Pengcheng and Jiang, Zhichen and Lu, Chao and Zhu, Qicong and Mou, Yiping and Jin, Weiwei},
title = {18F-FDG PET Radiomic Analysis to Predict Occult Liver Metastases of Pancreatic Ductal Adenocarcinoma},
journal = {Academic Radiology},
year = {2026},
volume = {33},
number = {1},
pages = {201--213},
doi = {10.1016/j.acra.2025.10.024}
}
EUVIMED